488 AEFI deaths, but not necessarily due to vax: Govt

New Delhi: Asserting that vaccines approved by the government are safe and the only weapon against coronavirus, the government on Tuesday said deaths reported post-vaccination standing at 488 were a small percentage of the number of doses given, but this did not mean they were due to vaccination.

“We ascertain if it is a minor adverse event or it is a serious or severe adverse event. Then it is monitored and causes are ascertained. The vaccines approved by us, their safety parameters are very good. When 23.5 crore doses were given, AEFI (adverse events following immunisation) deaths were 0.0002 per cent which comes to 488 deaths which does not mean these deaths were because of vaccination,” said Lav Agarwal, joint secretary in the health ministry.

AEFI is defined as ‘any untoward medical occurrence which follows immunisation’ and which does not necessarily have a causal relationship with the usage of the vaccine.

Reports in the media said one case of vaccine-related death was confirmed due to severe allergic reaction.

In a press statement issued earlier, the health ministry said there have been media reports suggesting an increase in the cases of severe AEFI that have also resulted in ‘succumbing of patients’ post-vaccination.

“It is clarified that these reports are based on incomplete and limited understanding of the matter at hand,” it stated.

  • Related Posts

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Shares of Mankind Pharma fell more than 2% on 16 October after the company announced that it has signed an agreement to acquire a 70% stake in Belgium-based biotechnology company…

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    NEW DELHI: Can a drug licensing authority suspend a pharmaceutical distributor’s licence while issuing a show-cause notice, before considering its response? The Karnataka high court has said the procedure under…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

    A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs